COL1A1 polymorphism is associated with risks of osteosarcoma susceptibility and death
- PMID: 24072491
- DOI: 10.1007/s13277-013-1172-6
COL1A1 polymorphism is associated with risks of osteosarcoma susceptibility and death
Abstract
Osteosarcoma is a life-threatening malignancy that often occurs in teenagers. Collagen type I alpha 1 (COL1A1) polymorphism is reportedly associated with the occurrence of several human diseases. However, the relationship between COL1A1 and osteosarcoma occurrence remains unknown, and there is no report about the prevalence of COL1A1 in osteosarcoma. The purpose of this study is to investigate the associations of COL1A1 polymorphism with the susceptibility and survival of osteosarcoma. The relative risk to develop osteosarcomas and the overall survival associated to COL1A1 polymorphism were investigated in a homogeneous group of 189 osteosarcomas patients. Correlations with overall survival and hazard ratios (HR) were also analyzed. CT genotype and C allele of COL1A1 at rs1061970, and CG genotype and G allele of COL1A1 at rs2075559 are associated with decreased susceptibility to osteosarcoma in the Chinese population. CC genotype and C allele of COL1A1 at rs1061970 are associated with nonmetastasis in patients. CC genotype and CT genotype of COL1A1 at rs1061970 are associated with lower risk of death. Metastasis was found to be an independent prognostic factor for survival. This study provides the first evidence for the association between COL1A1 polymorphism and osteosarcoma risk in Chinese and shows that COL1A1 polymorphism at rs1061970 has a prognostic value for overall survival in osteosarcoma patients.
Similar articles
-
Single nucleotide polymorphism of hsa-miR-124a affects risk and prognosis of osteosarcoma.Cancer Biomark. 2016 Jun 24;17(2):249-57. doi: 10.3233/CBM-160637. Cancer Biomark. 2016. PMID: 27540978
-
The efficacy and safety of Apatinib mesylate in the treatment of metastatic osteosarcoma patients who progressed after standard therapy and the VEGFR2 gene polymorphism analysis.Int J Clin Oncol. 2020 Jun;25(6):1195-1205. doi: 10.1007/s10147-020-01644-7. Epub 2020 Mar 25. Int J Clin Oncol. 2020. PMID: 32215805
-
Polymorphisms in TP53 are associated with risk and survival of osteosarcoma in a Chinese population.Int J Clin Exp Pathol. 2015 Mar 1;8(3):3198-203. eCollection 2015. Int J Clin Exp Pathol. 2015. PMID: 26045840 Free PMC article.
-
Prognostic value of microRNAs in osteosarcoma: A meta-analysis.Onco_target. 2017 Jan 31;8(5):8726-8737. doi: 10.18632/onco_target.14429. Onco_target. 2017. PMID: 28060730 Free PMC article. Review.
-
The association of glutathione S-transferase polymorphisms in patients with osteosarcoma: evidence from a meta-analysis.Eur J Cancer Care (Engl). 2015 May;24(3):417-24. doi: 10.1111/ecc.12197. Epub 2014 Apr 1. Eur J Cancer Care (Engl). 2015. PMID: 24689813 Review.
Cited by
-
hsa_circ_0020378 regulating miR-339-3p/COL1A1 promotes osteosarcoma progression.Cancer Biol Ther. 2023 Dec 31;24(1):2274120. doi: 10.1080/15384047.2023.2274120. Epub 2023 Nov 18. Cancer Biol Ther. 2023. PMID: 37978903 Free PMC article.
-
Role of five small nucleotide polymorphisms in the VEGF gene on the susceptibility to osteosarcoma and overall survival of patients.Oncol Lett. 2015 Sep;10(3):1481-1486. doi: 10.3892/ol.2015.3396. Epub 2015 Jun 19. Oncol Lett. 2015. PMID: 26622695 Free PMC article.
-
Effect of variation of FGF2 genotypes on the risk of osteosarcoma susceptibly: a case control study.Int J Clin Exp Med. 2015 Apr 15;8(4):6114-8. eCollection 2015. Int J Clin Exp Med. 2015. PMID: 26131213 Free PMC article.
-
The role of extracelluar matrix in osteosarcoma progression and metastasis.J Exp Clin Cancer Res. 2020 Sep 4;39(1):178. doi: 10.1186/s13046-020-01685-w. J Exp Clin Cancer Res. 2020. PMID: 32887645 Free PMC article. Review.
-
Association of COL1A1 rs1800012 polymorphism with musculoskeletal degenerative diseases: a meta-analysis.Onco_target. 2017 Sep 8;8(43):75488-75499. doi: 10.18632/onco_target.20797. eCollection 2017 Sep 26. Onco_target. 2017. PMID: 29088884 Free PMC article.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous